Edition:
India

Jubilant Life Sciences Ltd (JULS.NS)

JULS.NS on National Stock Exchange of India

719.15INR
25 Sep 2020
Change (% chg)

Rs20.15 (+2.88%)
Prev Close
Rs699.00
Open
Rs712.80
Day's High
Rs725.00
Day's Low
Rs705.00
Volume
293,721
Avg. Vol
699,280
52-wk High
Rs909.00
52-wk Low
Rs234.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2021 Jun 18,929.20 5.525
FY 2020 Mar '20 23,914.10 14.990
Dec 23,152.10 12.770
Sep 22,659.30 12.520
Jun 21,818.60 11.612
FY 2019 Mar '19 23,855.80 -6.363
Dec 23,771.00 16.742
Sep 22,694.90 13.505
Jun 20,786.50 13.000
FY 2018 Mar '18 22,519.60 9.930
Dec 20,677.60 13.642
Sep 16,420.40 8.230
Jun 15,960.50 9.440
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-20 2 24,894.00 25,491.00 24,297.00 25,131.00
Quarter Ending Mar-20 5 22,981.50 24,309.70 21,335.00 --
Year Ending Mar-20 6 90,668.70 91,939.70 87,693.00 --
Year Ending Mar-21 10 98,734.10 103,734.00 93,967.40 101,977.00
Year Ending Mar-22 9 105,995.00 115,918.00 99,452.50 106,391.00
Earnings (per share)
Quarter Ending Dec-20 1 18.00 18.00 18.00 16.59
Quarter Ending Mar-20 3 12.58 14.43 11.30 --
Year Ending Mar-20 6 53.66 58.00 46.10 --
Year Ending Mar-21 10 61.97 69.80 56.05 66.51
Year Ending Mar-22 9 71.72 89.80 64.20 71.91
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 18.47 31.14 33.53
P/E High - Last 5 Yrs. 23.22 40.50 45.20
P/E Low - Last 5 Yrs. 16.62 23.86 24.26
Beta 1.54 0.91 0.90
Price to Sales (TTM) 1.72 3.99 5.69
Price to Book (MRQ) -- 4.97 5.07
Price to Tangible Book (MRQ) -- 5.74 6.50
Price to Cash Flow (TTM) 12.55 23.03 23.51
% Owned Institutions -- 0.87 1.73

Dividends

  Company industry sector
Dividend Yield 0.45 1.55 1.49
Dividend Yield - 5 Year Avg 0.88 1.56 1.51
Dividend 5 Year Growth Rate 0.00 4.28 5.14
Payout Ratio(TTM) 8.52 45.75 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 9.78 2.37 10.57
Sales (TTM) vs TTM 1 Yr. Ago 4.88 4.65 5.71
Sales - 5 Yr. Growth Rate 6.90 9.86 10.05
EPS (MRQ) vs Qtr. 1 Yr. Ago -9.06 16.29 20.17
EPS (TTM) vs TTM 1 Yr. Ago 33.16 -- --
EPS - 5 Yr. Growth Rate 109.52 9.86 10.77
Capital Spending - 5 Yr. Growth Rate -5.46 15.10 14.97

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.33
Current Ratio (MRQ) -- 3.05 3.16
LT Debt to Equity (MRQ) -- 8.79 11.31
Total Debt to Equity (MRQ) -- 12.59 15.51
Interest Coverage (TTM) 2.76 41.12 36.66

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 57.51 54.55 54.39
Gross Margin - 5 Yr. Avg. 49.00 52.05 52.27
EBITD Margin (TTM) 21.38 -- --
EBITD - 5 Yr. Avg 18.88 18.46 11.96
Operating Margin (TTM) 16.63 14.38 5.41
Operating Margin - 5 Yr. Avg. 13.18 14.55 7.51
Pre-Tax Margin (TTM) 11.75 14.90 6.29
Pre-Tax Margin - 5 Yr. Avg. 6.51 14.98 8.02
Net Profit Margin (TTM) 9.02 11.09 2.52
Net Profit Margin - 5 Yr. Avg. 4.35 11.22 4.24
Effective Tax Rate (TTM) 23.29 23.42 23.33
Effective Tax Rate - 5 Yr. Avg. 33.23 23.64 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) 25,736,520 978,598,613 879,042,975
Net Income/Employee (TTM) 2,320,285 116,081,974 104,231,326
Receivable Turnover (TTM) -- 5.78 5.98
Inventory Turnover (TTM) -- 2.66 3.45
Asset Turnover (TTM) -- 0.98 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.90 11.45
Return on Assets - 5 Yr. Avg. 2.90 13.16 12.56
Return on Investment (TTM) -- 15.42 14.93
Return on Investment - 5 Yr. Avg. 4.21 17.10 16.29
Return on Equity (TTM) -- 16.77 16.49
Return on Equity - 5 Yr. Avg. 8.72 18.03 17.40
  1 Year 3 Year 5 Year
Sales % 1.92 1.15 6.90
EPS (TTM) % 47.16 75.35 109.52
Dividend % 0.00 0.00 0.00
Note: Units in Millions of US Dollars

Performance for Jubilant Life Sciences Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -4.74 -5.12 88 21
13 Week -6.89 -8.22 99 38
26 Week -18.25 -23.67 99 34
52 Week 5.25 -7.01 99 13
YTD 5.20 -11.96 99 26
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 19.20%
# of Holders: 51
Total Shares Held: 30,579,634
3 Mo. Net Change: -1,571,770
# New Positions: 5
# Closed Positions: 4
# Increased Positions: 13
# Reduced Positions: 16
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.